News and Events
BioCep Seeking Industry Collaboration for Beta Testing of its Automated Magnetic-based Cell Separation Technology
If you are a cell therapy company, contract development and manufacturing organization (CDMO), leading cancer center or industry equipment developer in the cell therapy market looking to enhance your cell separation process, please get in contact.
BioCep Change Focus to Rapidly Growing Personalized Production Industry for Cell Therapy
BioCep’s automated, immuno- magnetic-based cell separation technology offers significant advantages that overcome cited industry challenges in personalized CAR-T production.
BioCep Appoint New Leadership Team
Life Science Veteran, Uri Yogev, former Founder and CEO of Ethrog Biotechnology, acquired by Invitrogen (part of Thermo Fisher; NASDAQ: TMO) joins as CEO supported by highly-experienced new management team.